NRBO   $2.36  0.43% Market Closed

NeuroBo Pharmaceuticals Inc
Total Cash 28.05M
totalCashPerShare 3.315
EBITDA -26.51M
Total Debt 170.00K
quickRatio 2.888
currentRatio 2.937
Total Revenue
debtToEquity 0.897
Revenue/Share
ROA -0.57235
ROE -1.17355
grossProfits
freeCashflow -10.44M
operatingCashflow -19.90M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -6.39M
forwardPE -1.6117647
floatShares 2.06M
sharesOutstanding 8.49M
sharesShort 24.06K
sharesShortPriorMonth 33.26K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.66%
heldPercentInstitutions 0.12%
Short Ratio help_outline 0.41%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.304
Price To Book help_outline 1.19
earningsQuarterlyGrowth
netIncomeToCommon -25.90M
trailingEps -4.99%
forwardEps -1.70%
enterpriseToEbitda 0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 3Q 2024
institutionsCount 13
lastUpdated Nov. 7, 2024, 3:09 a.m.